© 1996 Oxford University Press
research-article |
Do Patients with Severe Asthma Run an Increased Risk from Ischaemic Heart Disease?
* Department of Occupational Medicine, Sahlgrenska University Hospital St Sigfridsgatan 85b, S-412 66 Göteborg, Sweden.
Department of Respiratory Medicine and Allergology, Sahlgrenska University Hospital Göteborg, Sweden
BACKGROUND: Knowledge of the mortality outcome of asthma is limited to hospital case series follow-up.
METHODS: To provide estimates of the mortality and cause of death in patients with asthma comparison of observed and expected number of deaths in patients with asthma for the observation period 1962–1986 was made. The study group was 262 patients aged 19–81 years with severe asthma. The group was a total sample of patients with a daily treatment of oral steroids more than one year, 1962–1963, from the city of Göteborg.
RESULTS: Mortality from all causes was significantly raised among the asthmatics (179 deaths versus 83.5 expected relative risk (RR) =2.1, 95% confidence interval (CI) : 1.8–2.5). There was an excess mortality from ischaemic heart disease 58 versus 29.9 deaths (RR = 1.9, 95% CI: 1.4–2.4), especially among women (RR =2.5, 95% CI : 1.7–3.3), However, there was also an increased mortality from asthma (39 versus 0.4 deaths) and chronic obstructive pulmonary disease (11 versus 0.5 deaths).
CONCLUSIONS: These findings suggest that subjects with severe asthma, especially women, have an increased mortality from ischaemic heart disease. The results may reflect confounding, mainly smoking and physical inactivity. Other explanations may be side effects of the anti-asthmatic drugs or an effect of longstanding airway obstruction
Keywords epidemiology, asthma, prognosis, corticosteroids, confounding, smoking
Revised 1 October 1995
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. S. Ponnoth, A. Nadeem, and S. J. Mustafa Adenosine-mediated alteration of vascular reactivity and inflammation in a murine model of asthma Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2158 - H2165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hazarika, M. R. Van Scott, and R. M. Lust Severity of myocardial injury following ischemia-reperfusion is increased in a mouse model of allergic asthma Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H572 - H579. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J G Schanen, C Iribarren, E Shahar, N M Punjabi, S S Rich, P D Sorlie, and A R Folsom Asthma and incident cardiovascular disease: the Atherosclerosis Risk in Communities Study Thorax, August 1, 2005; 60(8): 633 - 638. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ringbaek, N. Seersholm, and K. Viskum Standardised mortality rates in females and males with COPD and asthma Eur. Respir. J., May 1, 2005; 25(5): 891 - 895. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Wei, T. M. MacDonald, and B. R. Walker Taking Glucocorticoids by Prescription Is Associated with Subsequent Cardiovascular Disease Ann Intern Med, November 16, 2004; 141(10): 764 - 770. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Iribarren, I. V Tolstykh, and M. D Eisner Are patients with asthma at increased risk of coronary heart disease? Int. J. Epidemiol., August 1, 2004; 33(4): 743 - 748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. F Guite, R. Dundas, and P. G J Burney Risk factors for death from asthma, chronic obstructive pulmonary disease, and cardiovascular disease after a hospital admission for asthma Thorax, April 1, 1999; 54(4): 301 - 307. [Abstract] [Full Text]
|
|